FIELD: molecular biology.
SUBSTANCE: gene therapy vector containing an expression cassette that contains a transgene encoding lysosome-associated membrane protein 2B (LAMP-2B) or a functional variant thereof is described, wherein said transgene is codon-optimized for expression in a human host cell, and wherein the sequence of said transgene has at least 95% identity to the sequence selected from SEQ ID NO: 3-5. A pharmaceutical composition for treating or preventing Danon disease, containing a gene therapy vector, is also described. A method of treating or preventing Danon disease or other autophagic disorder in a subject in need thereof, comprising administering to said subject a gene therapy vector or pharmaceutical composition, is presented.
EFFECT: claimed invention expands the arsenal of remedies for Danon's disease.
30 cl, 10 dwg, 4 ex
| Title | Year | Author | Number |
|---|---|---|---|
| OPTIMIZED GENES AND EXPRESSION CASSETTES OF MINI-DYSTROPHIN AND THEIR APPLICATION | 2017 |
|
RU2753194C2 |
| METHODS FOR TREATMENT OF DANON'S DISEASE AND OTHER AUTOPHAGY DISORDERS | 2017 |
|
RU2777571C2 |
| IMPROVEMENT OF CLINICAL PARAMETERS THROUGH FACTOR VIII EXPRESSION | 2019 |
|
RU2799048C2 |
| GENE THERAPY FOR THE TREATMENT OF HEMOPHILIA A | 2017 |
|
RU2762257C2 |
| GENE THERAPY IN PATIENTS WITH FANCONI ANEMIA | 2017 |
|
RU2801241C2 |
| GENOTHERAPY CONSTRUCTIONS FOR TREATMENT OF WILSON'S DISEASE | 2020 |
|
RU2807158C2 |
| MODIFIED FACTOR IX, AS WELL AS COMPOSITIONS, METHODS AND OPTIONS FOR THE USE OF GENE TRANSFER INTO CELLS, ORGANS AND TISSUE | 2016 |
|
RU2811445C2 |
| CODON-OPTIMIZED EXPRESSION CASSETTES OF ACID α-GLUCOSIDASE AND METHODS OF USE THEREOF | 2019 |
|
RU2823353C2 |
| METHODS OF GENOTHERAPY USING FACTOR VIII (FVIII) GENE | 2018 |
|
RU2808274C2 |
| ISOLATED MODIFIED VPI CAPSID PROTEIN OF ADENO-ASSOCIATED VIRUS OF SEROTYPE 9 (AAV9), CAPSID AND VECTOR BASED THEREON | 2021 |
|
RU2825667C2 |
